Transparency Market Research
Active Pharmaceutical Ingredients (API) Market to Hit USD 331.3 billion by 2031 | Says Transparency Market Research Inc.
November 13, 2023 02:24 ET | Transparency Market Research
Wilmington, Delaware, United States, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global active pharmaceutical ingredients (API) market is projected to flourish at a CAGR...
logo 600X600.png
Cancer Supportive Care Products Market to Surpass US$ 44,915.7 Million by 2030, Says Coherent Market Insights (CMI)
April 10, 2023 08:40 ET | CMI
Burlingame, April 10, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, Global Cancer supportive care products Market is estimated to be valued at US$ 32,458.0 million in 2023 and is...
logo 600X600.png
Global Cattle Healthcare Market to Surpass US$ 13,500.9 Million by 2030, Says Coherent Market Insights (CMI)
January 24, 2023 09:45 ET | CMI
Burlingame, Jan. 24, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, Global Cattle Healthcare Market is estimated to be valued at US$ 8,313.5 million in 2022 and is expected to...
GMILogo_Vertical-Gradient.png
Lyophilized Injectable Drugs Market to hit USD 740 Billion by 2030, says Global Market Insights Inc.
October 11, 2022 06:10 ET | Global Market Insights Inc.
Selbyville, Delaware, Oct. 11, 2022 (GLOBE NEWSWIRE) -- The lyophilized injectable drugs market value is projected to reach USD 740 billion by 2030, according to a new research report by Global...
researchdrivelogo.jpg
Global Home Infusion Therapy Market Projected to Garner $49.5 Billion by 2027 and Witness Prominent Growth during the COVID-19 Pandemic – Exclusive Report [165 Pages] by Research Dive
September 20, 2021 09:00 ET | Research Dive
New York, USA, Sept. 20, 2021 (GLOBE NEWSWIRE) -- A research report published by Research dive on the global home infusion therapy market explains the impact of COVID-19 pandemic on the current...
researchdrivelogo.jpg
Global Home Infusion Therapy Market Predicted to Grow at a Revenue of $49.5 Billion at a CAGR of 11.7% during the Forecast Period, 2020-2027 – Exclusive Report [165 Pages] by Research Dive
June 03, 2021 09:00 ET | Research Dive
New York, USA, June 03, 2021 (GLOBE NEWSWIRE) -- According to a recent report by Research Dive, the global home infusion therapy market is anticipated to reach $49.5 billion by the end of 2026 at a...
ContraFect_LOGO_Web.jpg
ContraFect Announces Dr. Roger J. Pomerantz, Chief Executive Officer and Chairman, Invited as Keynote Speaker and Presenter in Maxim’s Infectious Disease Virtual Conference
April 21, 2020 07:00 ET | ContraFect Corporation
YONKERS, N.Y. , April 21, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals and SunGen Pharma File ANDA for an Antibiotic
January 03, 2019 07:30 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...
ContraFect_LOGO_Web.jpg
ContraFect to Present at 2nd International Symposium on Antimicrobial Hydrolytic Enzymes
November 01, 2018 07:00 ET | ContraFect Corporation
YONKERS, N.Y., Nov. 01, 2018 (GLOBE NEWSWIRE) --  ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody...
ContraFect_LOGO_Web.jpg
ContraFect to Present at the “Exploring the Antibiotic Pipeline 2018” Symposium and also to Present New Data on CF-301 (exebacase) at IDWeek 2018
September 25, 2018 07:00 ET | ContraFect Corporation
YONKERS, N.Y., Sept. 25, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody...